SAN FRANCISCO, 23 July, 2026 Uncountable, the AI platform for end-to-end product development, today announced it has received Frost & Sullivan’s 2026 Global Integrated Pharmaceutical R&D Platforms Technology Innovation Leadership Recognition
The recognition follows an independent, criteria-based evaluation of the company’s technology leverage and business impact.
Founded in 2016 and headquartered in San Francisco, Uncountable unifies the Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), Quality Control LIMS, Product Lifecycle Management (PLM), and Quality Management System (QMS) into a single, cloud-based environment built on a centralized, structured data model. By connecting research, quality, and manufacturing on one record, the platform replaces the fragmented tools that leave critical experimental and quality data trapped in silos.
In its analysis, Frost & Sullivan highlighted Uncountable’s shift from data accumulation to data utilization: structured, AI-ready data that preserves experimental context, connects with more than 400 laboratory instruments and enterprise systems, and supports advanced analytics and AI so scientists can move from record keeping to real-time decision support.
“Uncountable is redefining how life sciences organizations harness data, transforming fragmented information into a unified, actionable intelligence layer that accelerates decision-making across R&D and manufacturing,” said Unmesh Lal, Vice President, Healthcare & Life Sciences at Frost & Sullivan. “Unlike traditional point solutions such as standalone ELN or LIMS systems, the company delivers a unified architecture that integrates multiple functionalities into a single environment, positioning the platform as a comprehensive digital backbone rather than a discrete software tool.”
Frost & Sullivan also pointed to Uncountable’s enterprise-first execution: an in-house implementation team, phased site-by-site rollouts, and a focus on end-user adoption rather than technical requirements alone. The analysis cited Uncountable’s work with leading research institutions, including the Kalodimos Lab at St. Jude Children’s Research Hospital, where a centralized data platform and machine learning tools helped researchers save time, surface patterns faster, and accelerate experimental design.
“This recognition reflects what our customers experience every day: when R&D, quality, and manufacturing share one structured, connected system, teams stop rebuilding lost work and start compounding it,” said Noel Hollingsworth, CEO of Uncountable. “Structured data comes first, and it is what makes AI dependable. We are honored Frost & Sullivan sees the same future we are building toward.”
About Uncountable
Uncountable is the AI platform for end-to-end product development, helping research and product development teams centralize, structure, and leverage their data to accelerate innovation. Founded in 2016 and headquartered in San Francisco, Uncountable unifies ELN, LIMS, QC LIMS, PLM, and QMS on a single structured data model, connecting the full path from raw material through formulation to finished product. Learn more at uncountable.com.
About Frost & Sullivan
For more than six decades, Frost & Sullivan, The Growth Pipeline Company, has helped investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action. Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that demonstrate exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development, each the result of a rigorous analytical process of interviews, deep-dive analysis, and secondary research. Powering clients to a future shaped by growth. Learn more at frost.com.
.png)
